Innovation is one of the characteristic features of an emerging market and a necessity if that market wants to maintain constant growth. In the Mexican pharmaceutical market, there have been many projects geared towards drug development in recent years. Mexico is the 12th pharmaceutical market worldwide and 2nd in Latin America. Agencies like CONACYT (National Council for Science and Technology), Seciti (Ministry of Science, Technology and Innovation), and universities like UNAM and ITESM are some of the top generators of innovative products in Mexico.
Additionally, there is also innovation within the companies that drive the Mexican pharmaceutical market. Companies like Laboratorios Sophia and Zurich Pharma have gained access to niche sectors within the pharmaceutical landscape by incorporating innovative processes and techniques into their products in ophthalmology and cancer treatments respectively. Companies like these combine knowledge and passion to produce some of the more innovative medicines in the market.
These companies and many others will be speaking at BioPharma Mexico 2013 on October 29th and 30th talking about the strategies that have made them successful.